Peng Leong

CBO & Therapeutic Area Head, Brain Aging at BioAge Labs

Speaker

Dr. Peng Leong is Chief Business Officer at BioAge where he leads efforts to execute strategic transactions that convert prioritized drug targets into a portfolio of therapies for treating diseases of aging. He brings extensive experience in deal execution across the pharmaceutical industry, including establishing research collaborations with Lilly and Novartis, and leading the acquisition or sale of over $1 billion in product rights across roles at Kazia Therapeutics, Merck KGaA, and DRI Healthcare. Early in his career, Peng was a healthcare investment banker at CIBC World Markets and Piper Jaffray. He holds a PhD in Biochemistry from the University of Toronto and an MBA from UC Berkeley.